Jessica J. Taticchi represents United States-based and international clients in a variety of high-stakes complex commercial matters, with a focus on antitrust and consumer protection litigation and class actions. She also counsels clients on privacy legislation, cybersecurity monitoring, Office of Foreign Assets Control (OFAC) enforcement, and antitrust compliance.
Jess represents clients in a variety of industries, including pharmaceuticals, technology, construction materials, telecommunications, and foods. She defends alleged violations of federal and state antitrust laws as well as state law antitrust and consumer protection claims. She also assists clients with internal reviews and antitrust compliance. Jess has experience representing pharmaceutical companies in antitrust lawsuits and investigations, including defending clients in reverse payment, product hopping, and sham petitioning lawsuits as well as civil and criminal government investigations. She also counsels clients on issues relating to data privacy and cybersecurity. She participates in the ABA’s Antitrust Section and has been appointed the Young Lawyer Representative to the Federal and State Privacy Legislation Task Force during the 2019–2021 ABA year as well as the Privacy and Information Security Committee during the 2020–2021 ABA year.
Prior to joining Morgan Lewis, Jess worked as an antitrust associate at an international law firm in New York, where she was a member of a trial team defending antitrust allegations brought by a state agency.
While in law school, Jess was the executive editor of the Federal Circuit Bar Journal and a member of the moot court board. She also worked at the Office of Foreign Assets Control with the US Treasury Department, Enforcement Division, conducting government investigations of economic sanctions violations.
Jess also maintains an active pro bono practice, focusing on child welfare and impact litigation.
Defends a generic pharmaceutical manufacturer in civil litigation regarding alleged price fixing and market allocation.
Defends a generic pharmaceutical manufacturer against multiple putative class actions alleging that it entered into a so-called reverse payment with a branded manufacturer.
Secured dismissal of antitrust claims brought by the FTC against a life sciences company for purported sham petitioning before the Food and Drug Administration; affirmed by the US Court of Appeals for the Third Circuit.
Secured dismissal of class action complaint alleging Sherman Act violations regarding eSIM technology brought against a leading wireless carrier.
Obtained dismissal via summary judgment of price fixing claims brought against a construction materials company.
Participated in defense at trial of pharmaceutical manufacturer in so-called product-hoping claims brought by the New York Attorney General.
Defended pharmaceutical manufacturer against federal Sherman Act and state law consumer protection claims tied to so-called reverse payment between branded and generic manufacturer.
Conducted risk assessment of life science company’s customer contracts and pricing strategies.
Counseled financial services company on antitrust considerations related to joint venture.
Counseled oil and gas company on antitrust compliance after conducting internal audit of emails and documents.
The George Washington University Law School, 2013, J.D., Thurgood Marshall Scholar
College of William & Mary, 2008, B.B.A., Marketing, Philosophy
US Court of Appeals for the Third Circuit
US Court of Appeals for the Fourth Circuit
US District Court for the Eastern District of Pennsylvania
Awards and Affiliations
Member, Practice Group of the Year, Competition, Law360 (2017–2020)
Member, American Bar Association, Antitrust Section
Young Lawyer Representative, American Bar Association, Antitrust Section, Federal and State Privacy Legislation Task Force
Young Lawyer Representative, American Bar Association, Antitrust Section, Privacy and Information Security Committee